{"SLR NAME":"Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes","References":[{"title1":"15-day mortality and associated risk factors for hospitalized patients with COVID-19 in Wuhan, China: an ambispective observational cohort study","References":[{"title2":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia","References":[{"title3":"The 2019-nCoV Outbreak Joint Field Epidemiology Investigation Team, Li Q. Notes from the field: an outbreak of NCIP (2019-nCoV) infection in China : Wuhan, Hubei Province, 2019-2020."},{"title3":"A novel coronavirus genome identified in a cluster of pneumonia cases : Wuhan, China 2019-2020."},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Use of national pneumonia surveillance to describe influenza A(H7N9) virus epidemiology, China, 2004-2013."},{"title3":"A novel coronavirus emerging in China : key questions for impact assessment."},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus."},{"title3":"Transmission dynamics and control of severe acute respiratory syndrome."},{"title3":"Dynamically modeling SARS and other newly emerging respiratory illnesses: past, present, and future."},{"title3":"Coronavirus infections : more than just the common cold."},{"title3":"Another decade, another coronavirus."},{"title3":"SARS and MERS: recent insights into emerging coronaviruses."},{"title3":"MERS, SARS, and Ebola: the role of super-spreaders in infectious disease."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at January 2020."},{"title3":"How to maintain surveillance for novel influenza A H1N1 when there are too many cases to count."}]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title3":"The novel coronavirus originating in Wuhan, China: challenges for global health governance"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Chinese management guideline for COVID-19 (version 6.0)"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Middle East respiratory syndrome"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Predictors of mortality in Middle East respiratory syndrome (MERS)"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"The immunopathogenesis of sepsis in elderly patients"},{"title3":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Serial evaluation of the SOFA score to predict outcome in critically ill patients"},{"title3":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network"},{"title3":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study"},{"title3":"Acute pneumonia and the cardiovascular system"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015"},{"title3":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia"},{"title3":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality"},{"title3":"Cardiovascular complications of acute respiratory infections: current research and future directions"},{"title3":"Regulation of ACE2 in cardiac myocytes and fibroblasts"},{"title3":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]},{"title2":"Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan","References":[{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV)"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases"},{"title3":"Diagnosis and treatment of adults with community-acquired pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention [published online ahead of print February 24, 2020]. JAMA. https://doi.org/10.1001/jama.2020.2648."},{"title3":"Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China [published online ahead of print February 28, 2020]. N Engl J Med. https://doi.org/10.1056/NEJMoa2002032."},{"title3":"Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS"},{"title3":"Severe acute respiratory syndrome: clinical and laboratory manifestations"},{"title3":"Clinical manifestations and inflammatory cytokine responses in patients with severe acute respiratory syndrome"},{"title3":"SARS immunity and vaccination"},{"title3":"Prevalence, risk factors, and management of asthma in China: a national cross-sectional study"},{"title3":"Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China [published online ahead of print February 19, 2020]. Allergy. https://doi.org/10.1111/all.14238."},{"title3":"An increased prevalence of self-reported allergic rhinitis in major Chinese cities from 2005 to 2011"},{"title3":"ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation"},{"title3":"Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection"},{"title3":"Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes"},{"title3":"Wu C, Chen X, Cai Y, Xia Ja, Zhou X, Xu S, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China [published online ahead of print March 13, 2020]. JAMA Intern Med. https://doi.org/10.1001/jamainternmed.2020.0994."},{"title3":"Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, et al. Comorbidity and its impact on 1590 patients with Covid-19 in China: a nationwide analysis [published online ahead of print March 26, 2020]. Eur Respir J. https://doi.org/10.1183/13993003.00547-2020."},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Angiotensin-converting enzyme 2 is an essential regulator of heart function"},{"title3":"Diagnostic and prognostic value of very high serum lactate dehydrogenase in admitted medical patients"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study [published online ahead of print February 24, 2020]. Lancet Respir Med. https://doi.org/10.1016/S2213-2600(20)30079-5."},{"title3":"Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, et al. A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19 [published online ahead of print March 18, 2020]. N Engl J Med. https://doi.org/10.1056/NEJMoa2001282."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Lan L, Xu D, Ye G, Xia C, Wang S, Li Y, et al. Positive RT-PCR test results in patients recovered from COVID-19 [published online ahead of print February 27, 2020]. JAMA. https://doi.org/10.1001/jama.2020.2783."},{"title3":"Peeri NC, Shrestha N, Rahman MS, Zaki R, Tan Z, Bibi S, et al. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? [published online ahead of print February 22, 2020] Int J Epidemiol. https://doi.org/10.1093/ije/dyaa033."}]},{"title2":"A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China."},{"title3":"Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province."},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings."},{"title3":"In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds."},{"title3":"Small molecules targeting severe acute respiratory syndrome human coronavirus."},{"title3":"Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture."},{"title3":"Treatment with lopinavir/ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset."},{"title3":"Combination therapy with lopinavir/ritonavir, ribavirin and interferon-alpha for Middle East respiratory syndrome."},{"title3":"Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen."},{"title3":"Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity."},{"title3":"Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus."},{"title3":"Interferon-beta and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays."},{"title3":"Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-beta1b (MIRACLE trial): study protocol for a randomized controlled trial."},{"title3":"International Severe Acute Respiratory and Emerging Infections Consortium (ISARIC) home page ()."},{"title3":"Comparative effectiveness of combined favipiravir and oseltamivir therapy versus oseltamivir monotherapy in critically ill patients with influenza virus infection."},{"title3":"Coronavirus disease (COVID-2019) R&amp;D. Geneva: World Health Organization ()."},{"title3":"National Early Warning Score (NEWS) 2: standardising the assessment of acute-illness severity in the NHS. London: Royal College of Physicians, 2017 ()."},{"title3":"Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study."},{"title3":"Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data."},{"title3":"Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1)pdm09."},{"title3":"Early oseltamivir after hospital admission is associated with shortened hospitalization: a 5-year analysis of oseltamivir timing and clinical outcomes."},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study."},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients."},{"title3":"HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus."}]},{"title2":"Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study","References":[]}]},{"title1":"Corticosteroids for critically ill COVID-19 patients with cytokine release syndrome: a limited case series","References":[{"title2":"Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020; 10.1001/jama.2020.2648.","References":[]},{"title2":"Zhang C, Wu Z, Li JW, Zhao H, Wang GQ. The cytokine release syndrome (CRS) of severe COVID-19 and interleukin-6 receptor (IL-6R) antagonist tocilizumab may be the key to reduce the mortality. Int J Antimicrob Agents 2020;10.1016/j.ijantimicag.2020.105954.","References":[]},{"title2":"Lee N, Chan KC, Hui DS, et al. Effects of early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in adult patients. J Clin Virol 2004; 31: 304-9.","References":[]},{"title2":"Gomersall CD. Pro/con clinical debate: steroids are a key component in the treatment of SARS. Pro: yes, steroids are a key component of the treatment regimen for SARS. Crit Care 2004; 8: 105-7.","References":[]},{"title2":"Arabi YM, Mandourah Y, Al-Hameed F, et al. Corticosteroid therapy for critically ill patients with Middle East Respiratory Syndrome. Am J Respir Crit Care Med 2018; 197: 757-67.","References":[]}]},{"title1":"Corticosteroid treatment of patients with coronavirus disease 2019 (<styled-content style="fixed-case" toggle="no">COVID</styled-content>?19)","References":[{"title2":"A novel coronavirus from patients with pneumonia in China, 2019","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Inferring the hosts of coronavirus using dual statistical models based on nucleotide composition"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"2019 novel coronavirus (2019-nCoV) outbreak: a new challenge"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan"},{"title3":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China"},{"title3":"Novel Wuhan (2019-nCoV) coronavirus"},{"title3":"Severe acute respiratory syndrome coronavirus phylogeny: toward consensus"},{"title3":"Diagnosis and treatment of new coronavirus pneumonia (trial version 7) [J / OL]. Tianjin J Tradit Chin Med. 2020;1-5. http://kns.cnki.net/kcms/detail/12.1349.R.20200304.1638.006.html. Accessed 3 June 2020."},{"title3":"Clinical outcome of standardized oxygen therapy nursing strategy in COVID-19"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus"},{"title3":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection"},{"title3":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV"},{"title3":"Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients"},{"title3":"Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study"},{"title3":"C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early"},{"title3":"Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study"},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China"},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Human ipsc-derived cardiomyocytes are susceptible to Sars-Cov-2 infection"},{"title3":"Cardiovascular complications in COVID-19"},{"title3":"COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?"},{"title3":"Endothelial cell infection and endotheliitis in COVID-19"}]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"First case of 2019 novel coronavirus in the United States","References":[{"title3":"Pneumonia of unknown cause : China."},{"title3":"Novel coronavirus : China."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"2019 Novel coronavirus, Wuhan, China: 2019-nCoV situation summary."},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam."},{"title3":"Wuhan coronavirus (2019-nCoV) global cases"},{"title3":"Interim guidance for healthcare professionals: criteria to guide evaluation of patients under investigation (PUI) for 2019-nCoV."},{"title3":"Infection control. 2019 Novel coronavirus, Wuhan, China."},{"title3":"A randomized, controlled trial of ebola virus disease therapeutics."},{"title3":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV."},{"title3":"Interim guidelines for collecting, handling, and testing clinical specimens from patients under investigation (PUIs) for 2019 novel coronavirus (2019-nCoV)."},{"title3":"Real-time RT-PCR panel for detection 2019-novel coronavirus."},{"title3":"2019-novel coronavirus (2019-nCoV) real-time rRT-PCR panel primers and probes."},{"title3":"Information for laboratories. 2019 novel coronavirus, Wuhan, China."},{"title3":"GenBank overview"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Novel coronavirus outbreak 2020"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."}]},{"title2":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","References":[]},{"title2":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) in Mexico"},{"title3":"Critically ill patients with severe acute respiratory syndrome"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada"},{"title3":"KDIGO clinical practice guideline for acute kidney injury"},{"title3":"Wuhan: Britons to be evacuated as scientists estimate 44 000 cases of 2019-nCOV in the city"},{"title3":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome"},{"title3":"Short-term outcome of critically ill patients with severe acute respiratory syndrome"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries"},{"title3":"China built a hospital in 10 days to battle coronavirus"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Asymptomatic cases complicate efforts"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"},{"title3":"Practice of diagnosis and management of acute respiratory distress syndrome in mainland China: a cross-sectional study"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"}]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"Coronavirus disease 2019 (COVID-19). Situation report 63. 23 Mar 2020","References":[]},{"title2":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome","References":[]},{"title2":"A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)","References":[{"title3":"Distinguishing opinion from evidence in guidelines"},{"title3":"GRADE handbook, GRADE working group. 2013. https://gdt.gradepro.org/app/handbook/handbook.html. Accessed 22 Jan 2020."},{"title3":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations"},{"title3":"McMaster RARE-Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome"},{"title3":"Jin YH, Cai L, Cheng ZS, Cheng H, Deng T, Fan YP, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (Full version). Yixue Xinzhi. 2020;30(1):35-64. 10.12173/j.issn.1004-5511.2020.01.09 [Article in China]."},{"title3":"Chan JFW, Yuan S, Kok KH, To KKT, Chu HC, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020. 10.1016/S0140-6736(20)30154-9."},{"title3":"Health Emergency Office of National Health Commission of the PRC. Update on the epidemic of novel coronavirus (2019-nCoV) infected pneumonia as at 24:00 on 26 January. http://www.nhc.gov.cn/xcs/yqfkdt/202001/3882fdcdbfdc4b4fa4e3a829b62d518e.shtml. Accessed 26 Jan 2020."},{"title3":"Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020. https://doi.org/10.1038/s41586-020-2012-7."},{"title3":"Perlman S. Another decade, another coronavirus. N Engl J Med. 2020. 10.1056/NEJMe2001126."},{"title3":"Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020. 10.1056/NEJMoa2001017."},{"title3":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020. 10.1016/S0140-6736(20)30183-5."},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Middle East respiratory syndrome infection control and prevention guideline for healthcare facilities"},{"title3":"Image of pulmonary and diagnosis of atypicalnovel coronavirus (2019-nCoV) infected pneumonia: case series of 14 patients"},{"title3":"Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings"},{"title3":"Treatment of severe acute respiratory syndrome"},{"title3":"MERS-COV disease associated ARDS -a case report"},{"title3":"The possibility of using Lopinave/Litonawe (LPV/r) as treatment for novel coronavirus 2019-nCov pneumonia: a quick systematic review based on earlier coronavirus clinical studies"},{"title3":"Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques"},{"title3":"Treatment with lopinavir/ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset"},{"title3":"Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study"},{"title3":"Middle east respiratory syndrome (MERS): a systematic review"},{"title3":"Clinical analysis of 190 cases of outbreak with atypical pneumonia in Guangzhou in spring, 2003"},{"title3":"Use of glucocorticoid in treatment of severe acute respiratory syndrome cases"},{"title3":"Glucocorticoid-induced diabetes in severe acute respiratory syndrome: the impact of high dosage and duration of methylprednisolone therapy"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"}]},{"title2":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology","References":[{"title3":"Masters PS, Perlman, S (2013) Coronaviridae. In: Knipe DM, Howley P (eds) Fields Virology. Lippincott Williams and Wilkins, Philadelphia, PA, pp 825-858"},{"title3":"Coronavirus host range expansion and Middle East respiratory syndrome coronavirus emergence: biochemical mechanisms and evolutionary perspectives"},{"title3":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses"},{"title3":"Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus"},{"title3":"Coronavirus-associated pneumonia in previously healthy children"},{"title3":"Clinical disease in children associated with newly described coronavirus subtypes"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"van Boheemen S et al (2012) Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. MBio 3(6)"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Coronaviruses post-SARS: update on replication and pathogenesis"},{"title3":"WHO Cumulative number of reported probable cases of SARS. In: 2003"},{"title3":"http://www.who.int/csr/disease/coronavirus_infections/MERS_CoV_RA_20140613.pdf WUoM-CTfAtHaIRfA-RGLaoMAf"},{"title3":"WHO: Middle East respiratory syndrome coronavirus (MERS-CoV). http://www.who.int/emergencies/mers-cov/en/"},{"title3":"Replication and shedding of MERS-CoV in upper respiratory tract of inoculated dromedary camels"},{"title3":"Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia"},{"title3":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor"},{"title3":"A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"Clinical and laboratory findings of SARS in Singapore"},{"title3":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia"},{"title3":"Middle East respiratory syndrome coronavirus: a case-control study of hospitalized patients"},{"title3":"Middle East respiratory syndrome"},{"title3":"Severe acute respiratory syndrome"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"SARS: clinical virology and pathogenesis"},{"title3":"The pathology and pathogenesis of experimental severe acute respiratory syndrome and influenza in animal models"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"van den Brand JM et al (2014) The pathology and pathogenesis of experimental severe acute respiratory syndrome and influenza in animal models. J Comp Pathol 151(1):83-112"},{"title3":"Expression of lymphocytes and lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"A cluster of patients with severe acute respiratory syndrome in a chest ward in southern Taiwan"},{"title3":"Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle East respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014"},{"title3":"Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice"},{"title3":"Disease-promoting effects of type I interferons in viral, bacterial, and coinfections"},{"title3":"Age-dependent dysregulation of innate immunity"},{"title3":"Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis"},{"title3":"Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells"},{"title3":"Modeling the early events of severe acute respiratory syndrome coronavirus infection in vitro"},{"title3":"Temporal changes in cytokine/chemokine profiles and pulmonary involvement in severe acute respiratory syndrome"},{"title3":"Persistence of lung inflammation and lung cytokines with high-resolution CT abnormalities during recovery from SARS"},{"title3":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome"},{"title3":"Analysis of serum cytokines in patients with severe acute respiratory syndrome"},{"title3":"Human immunopathogenesis of severe acute respiratory syndrome (SARS)"},{"title3":"Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome"},{"title3":"An interferon-gamma-related cytokine storm in SARS patients"},{"title3":"A probable role for IFN-gamma in the development of a lung immunopathology in SARS"},{"title3":"Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment"},{"title3":"Chu H et al (2015) Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways. J Infect Dis 213(6):904-14"},{"title3":"Middle East respiratory syndrome coronavirus shows poor replication but significant induction of antiviral responses in human monocyte-derived macrophages and dendritic cells"},{"title3":"Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis"},{"title3":"High secretion of interferons by human plasmacytoid dendritic cells upon recognition of Middle East respiratory syndrome coronavirus"},{"title3":"Clinical progression and cytokine profiles of Middle East respiratory syndrome coronavirus infection"},{"title3":"Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity"},{"title3":"Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans"},{"title3":"A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo"},{"title3":"Mouse-passaged severe acute respiratory syndrome-associated coronavirus leads to lethal pulmonary edema and diffuse alveolar damage in adult but not young mice"},{"title3":"A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice"},{"title3":"SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism"},{"title3":"Age-related increases in PGD(2) expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice"},{"title3":"A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal disease"},{"title3":"Early upregulation of acute respiratory distress syndrome-associated cytokines promotes lethal disease in an aged-mouse model of severe acute respiratory syndrome coronavirus infection"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"Toll-like receptor 3 signaling via TRIF contributes to a protective innate immune response to severe acute respiratory syndrome coronavirus infection"},{"title3":"The PDZ-binding motif of severe acute respiratory syndrome coronavirus envelope protein is a determinant of viral pathogenesis"},{"title3":"Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesis"},{"title3":"Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasome"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques"},{"title3":"Asymptomatic Middle East respiratory syndrome coronavirus infection in rabbits"},{"title3":"Prophylaxis with a Middle East respiratory syndrome coronavirus (MERS-CoV)-specific human monoclonal antibody protects rabbits from MERS-CoV infection"},{"title3":"Infection with MERS-CoV causes lethal pneumonia in the common marmoset"},{"title3":"Intratracheal exposure of common marmosets to MERS-CoV Jordan-n3/2012 or MERS-CoV EMC/2012 isolates does not result in lethal disease"},{"title3":"Receptor variation and susceptibility to Middle East respiratory syndrome coronavirus infection"},{"title3":"Rapid generation of a mouse model for Middle East respiratory syndrome"},{"title3":"Animal models for SARS and MERS coronaviruses"},{"title3":"Animal models of Middle East respiratory syndrome coronavirus infection"},{"title3":"Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection"},{"title3":"Cockrell A et al (2016) A mouse model for MERS coronavirus-induced acute respiratory distress syndrome. Nature Microbiology 2:16226"},{"title3":"Li K et al (2017) Mouse-adapted MERS coronavirus causes lethal lung disease in human DPP4 knockin mice. Proceedings of the National Academy of Sciences 114(15):E3119-E3128"},{"title3":"Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane"},{"title3":"Interaction of SARS and MERS coronaviruses with the antiviral interferon response"},{"title3":"Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells"},{"title3":"Coronavirus papain-like proteases negatively regulate antiviral innate immune response through disruption of STING-mediated signaling"},{"title3":"Interferon and cytokine responses to SARS-coronavirus infection"},{"title3":"SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon"},{"title3":"Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain"},{"title3":"Fehr AR et al (2016) The Conserved Coronavirus Macrodomain Promotes Virulence and Suppresses the Innate Immune Response during Severe Acute Respiratory Syndrome Coronavirus Infection. mBio 7(6):e01721-16"},{"title3":"Severe acute respiratory syndrome coronavirus papain-like protease ubiquitin-like domain and catalytic domain regulate antagonism of IRF3 and NF-kappaB signaling"},{"title3":"Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists"},{"title3":"SARS-CoV nucleocapsid protein antagonizes IFN-beta response by targeting initial step of IFN-beta induction pathway, and its C-terminal region is critical for the antagonism"},{"title3":"Suppression of innate antiviral response by severe acute respiratory syndrome coronavirus M protein is mediated through the first transmembrane domain"},{"title3":"Middle East respiratory syndrome coronavirus M protein suppresses type I interferon expression through the inhibition of TBK1-dependent phosphorylation of IRF3"},{"title3":"The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists"},{"title3":"Initial viral load and the outcomes of SARS"},{"title3":"Proliferative growth of SARS coronavirus in Vero E6 cells"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand"},{"title3":"Macrophage-expressed IFN-beta contributes to apoptotic alveolar epithelial cell injury in severe influenza virus pneumonia"},{"title3":"Cellular inhibitor of apoptosis protein cIAP2 protects against pulmonary tissue necrosis during influenza virus infection to promote host survival"},{"title3":"T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice"},{"title3":"Adaptive immune cells temper initial innate responses"},{"title3":"Not so fast: adaptive suppression of innate immunity"},{"title3":"Transcriptomic analysis reveals a mechanism for a prefibrotic phenotype in STAT1 knockout mice during severe acute respiratory syndrome coronavirus infection"},{"title3":"Induction of alternatively activated macrophages enhances pathogenesis during severe acute respiratory syndrome coronavirus infection"},{"title3":"Genome wide identification of SARS-CoV susceptibility loci using the collaborative cross"},{"title3":"Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection"},{"title3":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome"},{"title3":"Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome"},{"title3":"Reghunathan R et al (2005) Expression profile of immune response genes in patients with Severe Acute Respiratory Syndrome. BMC Immunology 6:2"},{"title3":"SARS: systematic review of treatment effects"},{"title3":"Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study"},{"title3":"Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques"},{"title3":"Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study"},{"title3":"The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study"},{"title3":"High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome"},{"title3":"Corticosteroid treatment of severe acute respiratory syndrome in Hong Kong"},{"title3":"Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques"},{"title3":"Zumla A et al (2016) Coronaviruses:drug discovery and therapeutic options. Nat Rev Drug Discov 15(5):327-47"},{"title3":"IFNlambda is a potent anti-influenza therapeutic without the inflammatory side effects of IFNalpha treatment"},{"title3":"IFN-lambda resolves inflammation via suppression of neutrophil infiltration and IL-1beta production"},{"title3":"Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury"},{"title3":"The TLR4 antagonist Eritoran protects mice from lethal influenza infection"},{"title3":"Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection"},{"title3":"Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus"},{"title3":"Silencing of CCR2 in myocarditis"},{"title3":"Therapeutic siRNA silencing in inflammatory monocytes in mice"},{"title3":"Immunomodulatory therapy for severe influenza"},{"title3":"The effect of inhibition of PP1 and TNFalpha signaling on pathogenesis of SARS coronavirus"}]},{"title2":"Active MERS-CoV replication and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis","References":[]},{"title2":"Treatment with lopinavir/ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset","References":[{"title3":"HIV-associated tuberculosis in children and adolescents: evolving epidemiology, screening, prevention and management strategies"},{"title3":"Pharmacokinetics of adjusted-dose lopinavir-ritonavir combined with rifampin in healthy volunteers"},{"title3":"Pharmacokinetics of antiretroviral and tuberculosis drugs in children with HIV/TB co-infection: a systematic review"},{"title3":"Lopinavir-ritonavir super-boosting in young HIV-infected children on rifampicin-based tuberculosis therapy compared with lopinavir-ritonavir without rifampicin: a pharmacokinetic modelling and clinical study"},{"title3":"Lopinavir exposure is insufficient in children given double doses of lopinavir/ritonavir during rifampicin-based treatment for tuberculosis"},{"title3":"Empirical treatment against cytomegalovirus and tuberculosis in HIV-infected infants with severe pneumonia: study protocol for a multicenter, open-label randomized controlled clinical trial"},{"title3":"Blood sample volumes in child health research: review of safe limits"},{"title3":"Simultaneous determination of the HIV drugs indinavir, amprenavir, saquinavir, ritonavir, lopinavir, nelfinavir, the nelfinavir hydroxymetabolite M8, and nevirapine in human plasma by reversed-phase high-performance liquid chromatography"},{"title3":"The international interlaboratory quality control program for measurement of antiretroviral drugs in plasma: a global proficiency testing program"},{"title3":"Plasma lopinavir concentrations predict virological failure in a cohort of South African children initiating a protease-inhibitor-based regimen"},{"title3":"Pharmacokinetics of lopinavir/ritonavir crushed versus whole tablets in children"},{"title3":"Establishing dosing recommendations for efavirenz in HIV/TB-Coinfected children younger than 3 years"},{"title3":"Pharmacokinetics and safety of a raltegravir-containing regimen in children aged 4 Weeks to 2 Years living with human immunodeficiency virus and receiving rifampin for tuberculosis"},{"title3":"Pharmacokinetic interaction between raltegravir and rifampicin in an infant with HIV exposed to active TB: a case report"},{"title3":"Pharmacokinetics of nevirapine in HIV-infected children under 3 years on rifampicin-based antituberculosis treatment"},{"title3":"Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial"},{"title3":"Dolutegravir as first- or second-line treatment for HIV-1 infection in children"},{"title3":"Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial"}]},{"title2":"Inhibition of NF-kappaB-mediated inflammation in severe acute respiratory syndrome coronavirus-infected mice increases survival","References":[]},{"title2":"Corticosteroids in severe pneumonia","References":[{"title3":"COVID-19 diagnosis and treatment guideline (promulgated along decree 4689/QD-BYT on October 6th, 2021)"},{"title3":"Dexamethasone in hospitalized patients with Covid-19"},{"title3":"Coronavirus (COVID-19) Infection in Pregnancy"},{"title3":"Methylprednisolone achieves greater concentrations in the lung than prednisolone. A pharmacokinetic analysis"},{"title3":"Hospital-acquired infections in critically ill patients with COVID-19"}]},{"title2":"Systemic corticosteroid therapy may delay viral clearance in patients with Middle East respiratory syndrome coronavirus infection","References":[]},{"title2":"The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study","References":[]},{"title2":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected (WHO/2019-nCoV/clinical/2020.4)","References":[]},{"title2":"Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia] [Chinese]","References":[]},{"title2":"A review of treatment modalities for Middle East respiratory syndrome","References":[]},{"title2":"Arbidol (Umifenovir): a broad-spectrum antiviral drug that inhibits medically important arthropod-borne flaviviruses","References":[{"title3":"Flaviviral infections and potential targets for antiviral therapy"},{"title3":"The Emerging Zika Virus Epidemic in the Americas Research Priorities"},{"title3":"Virology, pathology, and clinical manifestations of West Nile virus disease"},{"title3":"Pathogenesis of West Nile virus infection: A balance between virulence, innate and adaptive immunity, and viral evasion"},{"title3":"Zika Virus: Medical Countermeasure Development Challenges"},{"title3":"Synthesis and Antiviral Activity of 5-Hydroxyindole Derivatives"},{"title3":"Arbidol: A broad-spectrum antiviral compound that blocks viral fusion"},{"title3":"The Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic Viruses"},{"title3":"Membranotropic Effects of Arbidol, a Broad Anti-Viral Molecule, on Phospholipid Model Membranes"},{"title3":"Characteristics of arbidol-resistant mutants of influenza virus: Implications for the mechanism of anti-influenza action of arbidol"},{"title3":"Arbidol: A broad-spectrum antiviral that inhibits acute and chronic HCV infection"},{"title3":"Biochemical mechanism of hepatitis C virus inhibition by the broad-spectrum antiviral arbidol"},{"title3":"Antiviral and anti-inflammatory activity of arbidol hydrochloride in influenza A (H1N1) virus infection"},{"title3":"Regulation of mammalian nucleotide metabolism and biosynthesis"},{"title3":"Prodrug approaches to improving the oral absorption of antiviral nucleotide analogues"},{"title3":"Pig Kidney Epithelial (Ps) Cells:Perfect Tool for Study of Flaviviruses and Some Other Arboviruses"},{"title3":"Morphological changes in human neural cells following tick-borne encephalitis virus infection"},{"title3":"A Simple Micro-Culture Method for Study of Group B Arboviruses"},{"title3":"Nucleoside Inhibitors of Tick-Borne Encephalitis Virus"},{"title3":"Virus morphogenesis and viral entry as alternative targets for novel hepatitis C antivirals"},{"title3":"Nucleoside analogs as a rich source of antiviral agents active against arthropod-borne Flaviviruses"},{"title3":"Monitoring of didanosine and stavudine intracellular trisphosphorylated anabolite concentrations in HIV-infected patients"},{"title3":"Differential Phosphorylation of Azidothymidine, Dideoxycytidine, and Dideoxyinosine in Resting and Activated Peripheral-Blood Mononuclear-Cells"},{"title3":"Cell-line dependent antiviral activity of sofosbuvir against Zika virus"},{"title3":"Adenosine Analog NITD008 Is a Potent Inhibitor of Zika Virus"},{"title3":"Nucleoside Inhibitors of Zika Virus"},{"title3":"Efficacy of the broad-spectrum antiviral compound BCX4430 against Zika virus in cell culture and in a mouse model"},{"title3":"The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication"},{"title3":"Sensitivity of various influenza virus strains to arbidol. Influence of arbidol combination with different antiviral drugs on reproduction of influenza virus A"},{"title3":"In vitro antiviral activity of arbidol against Chikungunya virus and characteristics of a selected resistant mutant"},{"title3":"Evaluation of Antiviral Efficacy of Ribavirin, Arbidol, and T-705 (Favipiravir) in a Mouse Model for Crimean-Congo Hemorrhagic Fever"},{"title3":"Efficacy of arbidol on lethal hantaan virus infections in suckling mice and in vitro"},{"title3":"Antiviral activity of arbidol against influenza A virus, respiratory syncytial virus, rhinovirus, coxsackie virus and adenovirus in vitro and in vivo"}]},{"title2":"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series","References":[]},{"title2":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","References":[{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China"},{"title3":"Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle East respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014"}]},{"title2":"H1N1 influenza A virus-associated acute lung injury: response to combination oseltamivir and prolonged corticosteroid treatment","References":[{"title3":"Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico"},{"title3":"Intensive-care patients with severe novel influenza A (H1N1) virus infection:Michigan, June 2009"},{"title3":"Emergence of a novel swine-origin influenza A (H1N1) virus in humans"},{"title3":"Hospitalized patients with novel influenza A (H1N1) virus infection:California, April-May, 2009"},{"title3":"Rello J, Rodriguez A, Ibanez P, Socias L, Cebrian J, group THNSw (2009) Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain. Crit Care 13:R148. http://ccforum.com/content/13/5/R148"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) in Mexico"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada"},{"title3":"A rationale for using steroids in the treatment of severe cases of H5N1 avian influenza"},{"title3":"Correlations between lung proinflammatory cytokine levels, virus replication, and disease after swine influenza virus challenge of vaccination-immune pigs"},{"title3":"Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia"},{"title3":"In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses"},{"title3":"Antiinflammatory action of glucocorticoids:new mechanisms for old drugs"},{"title3":"Clinical practice guidelines for the diagnosis and management of corticosteroid insufficiency in critical illness: recommendations of an international task force"},{"title3":"Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome. Evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to glucocorticoids"},{"title3":"Meduri G, Annane D, Chrousos G, Marik P, Sinclair S (2009) Activation and regulation of systemic inflammation in ARDS: rationale for prolonged glucocorticoid therapy. Chest 136. doi:10.1378/chest.1308-2408"},{"title3":"(August 7, 2009) Report to the President on US preparation for 2009-H1N1 Influenza. Office of the Press Secretary"},{"title3":"Corticosteroid treatment of severe acute respiratory syndrome in Hong Kong"},{"title3":"Treatment of severe acute respiratory syndrome with glucosteroids: the Guangzhou experience"},{"title3":"Medical treatment of viral pneumonia including SARS in immunocompetent adult"},{"title3":"SARS: systematic review of treatment effects"},{"title3":"Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study"},{"title3":"Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome"},{"title3":"Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial"},{"title3":"Steroid treatment in ARDS: a critical appraisal of the ARDS network trial and the recent literature"},{"title3":"Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis"},{"title3":"Tang B, Craig J, Eslick G, Seppelt I, McLean A (2009) World Health Organization. Pandemic (H1N1) 2009:update 58, 6 July 2009"},{"title3":"Tang B, Craig J, Eslick G, Seppelt I, McLean A (2009) United States Centers for Disease Control and Prevention. Interim guidance on specimen collection, processing, and testing for patients with suspected swine-origin influenza A (H1N1) virus infection. http://www.cdc.gov/h1n1flu/specimencollection.htm"},{"title3":"APACHE II: a severity of disease classification system"},{"title3":"The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine"},{"title3":"The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination"},{"title3":"An expanded definition of the adult respiratory distress syndrome"},{"title3":"Infectious diseases society of America/American thoracic society consensus guidelines on the management of community-acquired pneumonia in adults"},{"title3":"Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock"},{"title3":"Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review"},{"title3":"Glucocorticoid treatment in severe community-acquired pneumonia"},{"title3":"Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008"},{"title3":"Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network"},{"title3":"Screening of ARDS patients using standardized ventilator settings: influence on enrollment in a clinical trial"},{"title3":"Nuclear factor-kappaB:and glucocorticoid receptor alpha:mediated mechanisms in the regulation of systemic and pulmonary inflammation during sepsis and acute respiratory distress syndrome. Evidence for inflammation-induced target tissue resistance to glucocorticoids"},{"title3":"Prolonged glucocorticoid treatment in ARDS: evidence supporting effectiveness and safety"}]},{"title2":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study","References":[{"title3":"multi-country outbreak:update 34"},{"title3":"SARS coronavirus sequencing"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"Atypical pneumonia"},{"title3":"Guideline on management of severe acute respiratory syndrome (SARS)"},{"title3":"HA guidelines on severe acute respiratory syndrome"},{"title3":"The American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination"},{"title3":"APACHE II: a severity of disease classification system"},{"title3":"Rapid diagnosis of a coronavirus associated with severe acute respiratory syndrome (SARS)"},{"title3":"Differential role for T cells in the development of fibrotic lesions associated with reovirus 1/L-induced bronchiolitis obliterans organizing pneumonia versus acute respiratory distress syndrome"},{"title3":"Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fg12 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response"},{"title3":"Prevention of experimental coronavirus colds with intranasal alpha-2b interferon"},{"title3":"Radiological appearances of cytomegalovirus infections"},{"title3":"A case of influenza bronchiolitis complicated by pneumomediastinum and subcutaneous emphysema"}]},{"title2":"Hepatitis B virus-specific and global T-cell dysfunction in chronic hepatitis B","References":[{"title3":"Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells"},{"title3":"Pathogenesis of hepatitis B virus infection"},{"title3":"Management of hepatitis B: summary of a clinical research workshop"},{"title3":"Hepatitis B virus immunopathogenesis"},{"title3":"How I treat and monitor viral hepatitis B infection in patients receiving intensive immunosuppressive therapies or undergoing hematopoietic stem cell transplantation"},{"title3":"Chronic hepatitis B: update 2009"},{"title3":"EASL clinical practice guidelines: Management of chronic hepatitis B virus infection"},{"title3":"Interferon prevents formation of replication-competent hepatitis B virus RNA-containing nucleocapsids"},{"title3":"Immunobiology and pathogenesis of viral hepatitis"},{"title3":"Immunology of hepatitis B virus and hepatitis C virus infection"},{"title3":"The molecular basis of the failed immune response in chronic HBV: therapeutic implications"},{"title3":"Hepatitis B immunology for clinicians"},{"title3":"Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockade"},{"title3":"Bim-mediated deletion of antigen-specific CD8 T cells in patients unable to control HBV infection"},{"title3":"The third signal cytokine IL-12 rescues the anti-viral function of exhausted HBV-specific CD8 T cells"},{"title3":"Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T cells in persistent hepatitis B virus infection"},{"title3":"Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection"},{"title3":"Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection"},{"title3":"Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B"},{"title3":"Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV"},{"title3":"Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B"},{"title3":"Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients"},{"title3":"Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection"},{"title3":"Intrahepatic regulatory T cells are phenotypically distinct from their peripheral counterparts in chronic HBV patients"},{"title3":"Characteristics of Adults in the Hepatitis B Research Network in North America Reflect Their Country of Origin and Hepatitis B Virus Genotype"},{"title3":"Cloning of influenza cDNA ino M13: the sequence of the RNA segment encoding the A/PR/8/34 matrix protein"},{"title3":"T-cell response relative to genotype and ethnicity during antiviral therapy for chronic hepatitis C"},{"title3":"Influence of ethnicity in the outcome of hepatitis C virus infection and cellular immune response"},{"title3":"Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection"},{"title3":"Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection"},{"title3":"Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization"},{"title3":"Peripheral virus-specific T-cell interleukin-10 responses develop early in acute hepatitis C infection and become dominant in chronic hepatitis"},{"title3":"Immune tolerance split between hepatitis B virus precore and core proteins"},{"title3":"A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen"},{"title3":"Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection"},{"title3":"The size of the viral inoculum contributes to the outcome of hepatitis B virus infection"},{"title3":"CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection"},{"title3":"Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection"},{"title3":"Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B"},{"title3":"Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoire"},{"title3":"Effects of immunosuppressive therapy on hepatic expression of hepatitis B viral genome and gene products"},{"title3":"Hepatitis B reactivation in patients with previous hepatitis B virus exposure undergoing rituximab-containing chemotherapy for lymphoma: a prospective study"},{"title3":"American Gastroenterological Association Institute technical review on prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy"},{"title3":"Identification and in vitro expansion of functional antigen-specific CD25+ FoxP3+ regulatory T cells in hepatitis C virus infection"},{"title3":"Preserved T-cell function in children and young adults with immune-tolerant chronic hepatitis B"},{"title3":"Increased levels of arginase in patients with acute hepatitis B suppress antiviral T cells"},{"title3":"Oscillating CD8(+) T cell effector functions after antigen recognition in the liver"},{"title3":"Mobilizing monocytes to cross-present circulating viral antigen in chronic infection"},{"title3":"Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B"},{"title3":"A longitudinal study on the natural history of serum hepatitis B surface antigen changes in chronic hepatitis B"},{"title3":"The role of HBsAg quantification for monitoring natural history and treatment outcome"},{"title3":"Prediction of sustained response to peginterferon alfa-2b for hepatitis B e antigen-positive chronic hepatitis B using on-treatment hepatitis B surface antigen decline"}]},{"title2":"Drug treatment options for the 2019-new coronavirus (2019-nCoV)","References":[]},{"title2":"[Efficacies of lopinavir/ritonavir and abidol in the treatment of novel coronavirus pneumonia] [Chinese]","References":[]}]},{"title1":"Prolonged Low-Dose Methylprednisolone in Patients With Severe COVID-19 Pneumonia","References":[{"title2":"Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response","References":[]},{"title2":"Covid-19 in critically ill patients in the Seattle region:case series","References":[{"title3":"Novel coronavirus : China"},{"title3":"Coronavirus COVID-19 global cases"},{"title3":"First case of 2019 novel coronavirus in the United States."},{"title3":"2019 Novel coronavirus outbreak (COVID-19)"},{"title3":"Cryptic transmission of novel coronavirus revealed by genomic epidemiology"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study."},{"title3":"Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response."},{"title3":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State."},{"title3":"Priorities for the US health community responding to COVID-19."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Coronavirus disease 2019 (COVID-19)"},{"title3":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR."},{"title3":"Clinical characteristics of coronavirus disease 2019 in China."},{"title3":"Early neuromuscular blockade in the acute respiratory distress syndrome."},{"title3":"Prone positioning in severe acute respiratory distress syndrome."},{"title3":"Bacterial coinfection in influenza: a grand rounds review."},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study."},{"title3":"Effects of early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in adult patients."},{"title3":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome."},{"title3":"Corticosteroids as adjunctive therapy in the treatment of influenza: an updated Cochrane systematic review and meta-analysis."},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China."},{"title3":"Care of the critically ill and injured during pandemics and disasters: groundbreaking results from the Task Force on Mass Critical Care."},{"title3":"Introduction and executive summary: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement."}]},{"title2":"Respiratory intensive care units in Italy: a national census and prospective cohort study","References":[]},{"title2":"Early consensus management for non-ICU acute respiratory failure SARS-CoV-2 emergency in Italy: from ward to trenches","References":[{"title3":"The response of Milan's Emergency Medical System to the COVID-19 outbreak in Italy"},{"title3":"A novel coronavirus (COVID-19) outbreak: a call for action"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China"},{"title3":"BjornAage Ibsen"}]},{"title2":"Complex immune dysregulation in COVID-19 patients with severe respiratory failure","References":[{"title3":"COVID-19: a novel coronavirus and a novel challenge for critical care"},{"title3":"Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome"},{"title3":"Effect of the novel influenza A (H1N1) virus in the human immune system"},{"title3":"Inhibition of caspase-1 activation in Gram-negative sepsis and experimental endotoxemia"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Macrophage activation-like syndrome: an immunological entity associated with rapid progression to death in sepsis"},{"title3":"Monocytic HLA-DR expression in intensive care patients: interest for prognosis and secondary infection prediction"},{"title3":"IL-6 down-regulates HLA class II expression and IL-12 production of human dendritic cells to impair activation of antigen-specific CD4(+) T cells"},{"title3":"Dysregulation of immune response in patients with COVID-19 in Wuhan, China"},{"title3":"Indication for a role of regulatory T cells for the advent of influenza A (H1N1)-related pneumonia"},{"title3":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)"},{"title3":"Breadth of concomitant immune responses prior to patient recovery: a case-report of non-severe COVID-10"}]},{"title2":"Rationale for prolonged corticosteroid treatment in the acute respiratory distress syndrome caused by coronavirus disease 2019","References":[{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China."},{"title3":"Idiopathic pulmonary fibrosis in adult respiratory distress syndrome. Diagnosis and treatment."},{"title3":"Guidelines for the diagnosis and management of Critical Illness-Related Corticosteroid Insufficiency (CIRCI) in critically ill patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017."},{"title3":"Dexamethasone treatment for the acute respiratory distress syndrome: A multicentre, randomised controlled trial."},{"title3":"Prolonged glucocorticoid treatment is associated with improved ARDS outcomes: Analysis of individual patients' data from four randomized trials and trial-level meta-analysis of the updated literature."},{"title3":"Hydrocortisone infusion for severe community-acquired pneumonia: A preliminary randomized study."},{"title3":"Hydrocortisone treatment in early sepsis-associated acute respiratory distress syndrome: Results of a randomized controlled trial."},{"title3":"Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: A randomized controlled trial."},{"title3":"Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome."},{"title3":"Methylprednisolone infusion in early severe ARDS: Results of a randomized controlled trial."},{"title3":"COVID-19: Consider cytokine storm syndromes and immunosuppression."},{"title3":"Activation and regulation of systemic inflammation in ARDS: Rationale for prolonged glucocorticoid therapy."},{"title3":"Severe COVID-19 pneumonia: Assessing inflammation burden with volume-rendered chest CT."},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome."},{"title3":"Corticosteroid therapy for critically ill patients with the Middle East Respiratory Syndrome."},{"title3":"The influence of corticosteroid treatment on the outcome of influenza A(H1N1pdm09)-related critical illness."},{"title3":"Corticosteroids as adjunctive therapy in the treatment of influenza: An updated cochrane systematic review and meta-analysis."},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"The effect of corticosteroids on mortality of patients with influenza pneumonia: A systematic review and meta-analysis."},{"title3":"Clinical recommendations from an observational study on MERS: Glucocorticoids was benefit in treating SARS patients."},{"title3":"Effect of low-to-moderate-dose corticosteroids on mortality of hospitalized adolescents and adults with influenza A(H1N1)pdm09 viral pneumonia."},{"title3":"National institute for the infectious diseases &quot;L. Spallanzani&quot;, IRCCS. Recommendations for COVID-19 clinical management."},{"title3":"Treatment of severe acute respiratory syndrome with glucosteroids: The Guangzhou experience."},{"title3":"An exploratory reanalysis of the randomized trial on efficacy of corticosteroids as rescue therapy for the late phase of acute respiratory distress syndrome."}]},{"title2":"Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome","References":[]},{"title2":"Acute respiratory distress syndrome: the Berlin definition","References":[]},{"title2":"National Institute for the Infectious Diseases &quot;L. Spallanzani&quot;, IRCCS. Recommendations for COVID-19 clinical management","References":[]},{"title2":"Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on &quot;sepsis-related problems&quot; of the European Society of Intensive Care Medicine","References":[]},{"title2":"Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19","References":[]},{"title2":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","References":[]},{"title2":"Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis","References":[]},{"title2":"General adaptation in critical illness: glucocorticoid receptor-alpha master regulator of homeostatic corrections","References":[{"title3":"Linking cellular stress responses to systemic homeostasis"},{"title3":"The concept of allostasis in biology and biomedicine"},{"title3":"Endocrine changes in critical illness"},{"title3":"Evolutionary origins and functions of the stress response"},{"title3":"Immune-neuro-endocrine reflexes, circuits, and networks: physiologic and evolutionary implications"},{"title3":"Importance of the glucocorticoid stress response in a changing world: theory, hypotheses and perspectives"},{"title3":"Chronic inflammatory systemic diseases: an evolutionary trade-off between acutely beneficial but chronically harmful programs"},{"title3":"Stress and disorders of the stress system"},{"title3":"Activation of innate immunity system during aging: NF-kB signaling is the molecular culprit of inflamm-aging"},{"title3":"Molecular evolution of the NF-kappaB signaling system"},{"title3":"Activation and regulation of systemic inflammation in ARDS: rationale for prolonged glucocorticoid therapy"},{"title3":"Coactivation of GR and NFKB alters the repertoire of their binding sites and target genes"},{"title3":"A database and functional annotation of NF-kappa B target genes"},{"title3":"A genomic storm in critically injured humans"},{"title3":"Stress, the stress system and the role of glucocorticoids"},{"title3":"Turning up the heat: immune brinksmanship in the acute-phase response"},{"title3":"Critical illness-related corticosteroid insufficiency (CIRCI): a narrative review from a multispecialty task force of the society of critical care medicine (SCCM) and the European Society of Intensive Care Medicine (ESICM)"},{"title3":"Chronic critical illness and the persistent inflammation, immunosuppression, catabolism syndrome"},{"title3":"Cytokine dysregulation, inflammation and well-being"},{"title3":"Changes in macrophage phenotype as the immune response evolves"},{"title3":"Mitochondrial allostatic load puts the 'gluc' back in glucocorticoids"},{"title3":"Infections and the inflammatory response in acute respiratory distress syndrome"},{"title3":"Molecular inflammatory responses measured in blood of patients with severe community-acquired pneumonia"},{"title3":"Circulating cytokines as markers of systemic inflammatory response in severe community-acquired pneumonia"},{"title3":"Determinants of short and long term functional recovery after hospitalization for community-acquired pneumonia in the elderly: role of inflammatory markers"},{"title3":"Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) study"},{"title3":"Systemic and bronchoalveolar cytokines as predictors of in-hospital mortality in severe community-acquired pneumonia"},{"title3":"Contrasting inflammatory responses in severe and non-severe community-acquired pneumonia"},{"title3":"Immunological characterization of compensatory anti-inflammatory response syndrome in patients with severe sepsis: a longitudinal study*"},{"title3":"The host response in patients with sepsis developing intensive care unit-acquired secondary infections"},{"title3":"Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time"},{"title3":"Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome"},{"title3":"Nuclear factor-kappaB- and glucocorticoid receptor alpha- mediated mechanisms in the regulation of systemic and pulmonary inflammation during sepsis and acute respiratory distress syndrome. Evidence for inflammation-induced target tissue resistance to glucocorticoids"},{"title3":"Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury"},{"title3":"Interleukin-8 and soluble intercellular adhesion molecule-1 during acute respiratory distress syndrome and in response to prolonged methylprednisolone treatment"},{"title3":"Plasma cytokines IL-6, IL-8, and IL-10 are associated with the development of acute respiratory distress syndrome in patients with severe traumatic brain injury"},{"title3":"Role of NF kappa B in the mortality of sepsis"},{"title3":"Increased nuclear factor kB activation in critically ill patients who die"},{"title3":"Predictive value of nuclear factor kappaB activity and plasma cytokine levels in patients with sepsis"},{"title3":"Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569]"},{"title3":"D-dimer levels in assessing severity and clinical outcome in patients with community-acquired pneumonia. A secondary analysis of a randomised clinical trial"},{"title3":"Comparative analysis of the host response to community-acquired and hospital-acquired pneumonia in critically Ill patients"},{"title3":"Causes and consequences of coagulation activation in sepsis: an evolutionary medicine perspective"},{"title3":"Stress-induced glucocorticoids as a neuroendocrine alarm signal of danger"},{"title3":"Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis"},{"title3":"Long-term host immune response trajectories among hospitalized patients with sepsis"},{"title3":"Protracted immune disorders at one year after ICU discharge in patients with septic shock"},{"title3":"Inflammation versus glucocorticoids as purveyors of pathology during stress: have we reached the tipping point?"},{"title3":"A functional genomic fingerprint of chronic stress in humans: blunted glucocorticoid and increased NF-kappaB signaling"},{"title3":"Effects of aging on inflammation and hemostasis through the continuum of critical illness"},{"title3":"Consumptive coagulopathy is associated with organ dysfunction during PICS"},{"title3":"Fueling inflamm-aging through mitochondrial dysfunction: mechanisms and molecular targets"},{"title3":"Stress and glucocorticoid receptor regulation of mitochondrial gene expression"},{"title3":"Circulating mitochondrial DNA increases with age and is a familiar trait: implications for &quot;inflamm-aging&quot;"},{"title3":"Risk of cardiovascular events in survivors of severe sepsis"},{"title3":"Epigenetic upregulation of FKBP5 by aging and stress contributes to NF-kappaB-driven inflammation and cardiovascular risk"},{"title3":"A dysregulated balance of proinflammatory and anti-inflammatory host cytokine response early during therapy predicts persistence and mortality in Staphylococcus aureus bacteremia"},{"title3":"Stentz Infections F, SIRS, and CARS during ARDS and in response to prolonged glucocorticoid treatment [Abstract]"},{"title3":"Genome-wide transcription profiling of human sepsis: a systematic review"},{"title3":"Scavenger receptor class B, type I (SR-BI) is the major route for the delivery of high density lipoprotein cholesterol to the steroidogenic pathway in cultured mouse adrenocortical cells"},{"title3":"Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis"},{"title3":"Relationship of hypolipidemia to cytokine concentrations and outcomes in critically ill surgical patients"},{"title3":"Changes in HDL-associated apolipoproteins relate to mortality in human sepsis and correlate to monocyte and platelet activation"},{"title3":"SR-BI protects against endotoxemia in mice through its roles in glucocorticoid production and hepatic clearance"},{"title3":"HDL-cholesterol level and cortisol response to synacthen in critically ill patients"},{"title3":"Gluco- and mineralocorticoid biological effects of a 7-day treatment with low doses of hydrocortisone and fludrocortisone in septic shock"},{"title3":"Hench Lecture Award: The Evolution of Glucocorticoids"},{"title3":"Comprehensive overview of the structure and regulation of the glucocorticoid receptor"},{"title3":"Novel insights into the molecular mechanisms underlying generalized glucocorticoid resistance and hypersensitivity syndromes"},{"title3":"Protein evolution by molecular tinkering: diversification of the nuclear receptor superfamily from a ligand-dependent ancestor"},{"title3":"Glucocorticoid receptor"},{"title3":"Uterine glucocorticoid receptors are critical for fertility in mice through control of embryo implantation and decidualization"},{"title3":"Glucocorticoid receptor is required for foetal heart maturation"},{"title3":"Minireview: glucocorticoid regulation of lung development: lessons learned from conditional GR knockout mice"},{"title3":"Glucocorticoid receptor isoform-specific regulation of development, circadian rhythm, and inflammation in mice"},{"title3":"Mothers' attachment is linked to their children's anti-inflammatory gene expression via maternal warmth"},{"title3":"Why do we need nongenomic glucocorticoid mechanisms?"},{"title3":"Glucocorticoid receptors, in human alveolar macrophages and peripheral blood cells"},{"title3":"Decreased glucocorticoid receptor expression during critical illness"},{"title3":"Glucocorticoid signaling: an update from a genomic perspective"},{"title3":"A genome-wide signature of glucocorticoid receptor binding in neuronal PC12 cells"},{"title3":"Glucocorticoids and their receptors: insights into specific roles in mitochondria"},{"title3":"Stress and corticosteroids regulate rat hippocampal mitochondrial DNA gene expression via the glucocorticoid receptor"},{"title3":"Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells"},{"title3":"Differentiation of human pulmonary type II cells in vitro by glucocorticoid plus cyclic AMP"},{"title3":"Kruppel-like factor 13 is a major mediator of glucocorticoid receptor signaling in cardiomyocytes and protects these cells from DNA damage and death"},{"title3":"Glucocorticoid receptor-dependent gene regulatory networks"},{"title3":"Human glucocorticoid receptor beta regulates gluconeogenesis and inflammation in mouse liver"},{"title3":"The human glucocorticoid receptor as an RNA-binding protein: global analysis of glucocorticoid receptor-associated transcripts and identification of a target RNA motif"},{"title3":"Increased glucocorticoid receptor expression and activity mediate the LPS resistance of SPRET/EI mice"},{"title3":"Physiological functions of glucocorticoids in stress and their relation to pharmacological actions"},{"title3":"The five Rs of glucocorticoid action during inflammation: ready, reinforce, repress, resolve, and restore"},{"title3":"Glucocorticoids sensitize the innate immune system through regulation of the NLRP3 inflammasome"},{"title3":"Acute phase reaction and acute phase proteins"},{"title3":"Cytokines and the hypothalamic-pituitary-adrenal axis"},{"title3":"Synergistic roles of interleukin-6, interleukin-1, and tumor necrosis factor in the adrenocorticotropin response to bacterial lipopolysaccharide in vivo"},{"title3":"Tumor necrosis factor-alpha regulates steroidogenesis, apoptosis, and cell viability in the human adrenocortical cell line NCI-H295R"},{"title3":"Systemic immune challenge activates an intrinsically regulated local inflammatory circuit in the adrenal gland"},{"title3":"Induction of 11beta-hydroxysteroid dehydrogenase type 1 but not-2 in human aortic smooth muscle cells by inflammatory stimuli"},{"title3":"Proinflammatory actions of glucocorticoids: glucocorticoids and TNFalpha coregulate gene expression in vitro and in vivo"},{"title3":"Dominance of the strongest: inflammatory cytokines versus glucocorticoids"},{"title3":"Effects of methylprednisolone on intracellular bacterial growth"},{"title3":"Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome. Evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to glucocorticoids"},{"title3":"Pharmacological strategies for improving the efficacy and therapeutic ratio of glucocorticoids in inflammatory lung diseases"},{"title3":"Glucocorticoid receptor signaling in health and disease"},{"title3":"Glucocorticoid-independent modulation of GR activity: implications for immunotherapy"},{"title3":"Annexin A1 and glucocorticoids as effectors of the resolution of inflammation"},{"title3":"Annexin A1 modulates natural and glucocorticoid-induced resolution of inflammation by enhancing neutrophil apoptosis"},{"title3":"The role and effects of glucocorticoid-induced leucine zipper in the context of inflammation resolution"},{"title3":"Glucocorticoids promote nonphlogistic phagocytosis of apoptotic leukocytes"},{"title3":"Glucocorticoid-mediated regulation of granulocyte apoptosis and macrophage phagocytosis of apoptotic cells: implications for the resolution of inflammation"},{"title3":"Glucocorticoids induce protein S-dependent phagocytosis of apoptotic neutrophils by human macrophages"},{"title3":"Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes"},{"title3":"Saturated-efferocytosis generates pro-resolving CD11blow macrophages: Modulation by resolvins and glucocorticoids"},{"title3":"Local amplification of glucocorticoids by 11 beta-hydroxysteroid dehydrogenase type 1 promotes macrophage phagocytosis of apoptotic leukocytes"},{"title3":"Local amplification of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1 and its role in the inflammatory response"},{"title3":"Glucocorticoids promote survival of anti-inflammatory macrophages via stimulation of adenosine receptor A3"},{"title3":"Modulation of phagocytosis of apoptotic neutrophils by supernatant from dexamethasone-treated macrophages and annexin-derived peptide Ac(2-26)"},{"title3":"New lives given by cell death: macrophage differentiation following their encounter with apoptotic leukocytes during the resolution of inflammation"},{"title3":"Glucocorticoid resistance as a major drive in sepsis pathology"},{"title3":"Systemic inflammation-associated glucocorticoid resistance and outcome of ARDS"},{"title3":"Adrenal function and dysfunction in critically ill patients"},{"title3":"Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative beta isoform: a mechanism for the generation of glucocorticoid resistance"},{"title3":"Expression of the glucocorticoid receptor is decreased in experimental Staphylococcus aureus sepsis"},{"title3":"Cecal ligation and puncture alters glucocorticoid receptor expression"},{"title3":"Down regulation of hepatic glucocorticoid receptors after endotoxin treatment"},{"title3":"Nitric oxide up-regulates the glucocorticoid receptor and blunts the inflammatory reaction in porcine endotoxin sepsis"},{"title3":"[Effects of different doses of hydrocortisone on acute lung injury in rats with early septic shock induced by Escherichia coli]"},{"title3":"Glucocorticoid receptor expression on acute lung injury induced by endotoxin in rats"},{"title3":"Endothelial glucocorticoid receptor is required for protection against sepsis"},{"title3":"Modulation of glucocorticoid receptor expression, inflammation, and cell apoptosis in septic guinea pig lungs using methylprednisolone"},{"title3":"Low-dose dexamethasone alleviates lipopolysaccharide-induced acute lung injury in rats and upregulates pulmonary glucocorticoid receptors"},{"title3":"Mice with an increased glucocorticoid receptor gene dosage show enhanced resistance to stress and endotoxic shock"},{"title3":"Decreased cytosolic glucocorticoid receptor levels in critically ill patients"},{"title3":"Glucocorticoid receptor mRNA levels are selectively decreased in neutrophils of children with sepsis"},{"title3":"Reduced glucocorticoid receptor protein expression in children with critical illness"},{"title3":"Corticosteroid resistance in sepsis is influenced by microRNA-124-induced downregulation of glucocorticoid receptor-alpha"},{"title3":"Tissue mRNA expression of the glucocorticoid receptor and its splice variants in fatal critical illness"},{"title3":"An expanded definition of the adult respiratory distress syndrome"},{"title3":"Endothelial response to glucocorticoids in inflammatory diseases"},{"title3":"Glycocalyx and sepsis-induced alterations in vascular permeability"},{"title3":"Dexamethasone potentiates in vitro blood-brain barrier recovery after primary blast injury by glucocorticoid receptor-mediated upregulation of ZO-1 tight junction protein"},{"title3":"Endothelial biomarkers in human sepsis: pathogenesis and prognosis for ARDS"},{"title3":"Dysregulation of the angiopoietin-Tie-2 axis in sepsis ARDS"},{"title3":"Angiopoietin-1 and angiopoietin-2 as clinically informative prognostic biomarkers of morbidity and mortality in severe sepsis"},{"title3":"Endothelial activation and blood-brain barrier injury as risk factors for Delirium in critically Ill patients"},{"title3":"Vitamin C revisited"},{"title3":"Microcirculatory alterations: potential mechanisms and implications for therapy"},{"title3":"The role of adrenal gland microenvironment in the HPA axis function and dysfunction during sepsis"},{"title3":"Von Willebrand factor antigen is an independent marker of poor outcome in patients with early acute lung injury"},{"title3":"Plasma vascular endothelial growth factor in severe sepsis"},{"title3":"Circulating endothelial cells in patients with septic shock"},{"title3":"Evaluation of endothelial damage in sepsis-related ARDS using circulating endothelial cells"},{"title3":"Microcirculatory alterations in patients with severe sepsis: impact of time of assessment and relationship with outcome"},{"title3":"A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1"},{"title3":"Glucocorticoids and endothelial cell barrier function"},{"title3":"Glucocorticoids limit acute lung inflammation in concert with inflammatory stimuli by induction of SphK1"},{"title3":"Dexamethasone coordinately regulates angiopoietin-1 and VEGF: a mechanism of glucocorticoid-induced stabilization of blood-brain barrier"},{"title3":"Serum glucocorticoid inducible kinase (SGK)-1 protects endothelial cells against oxidative stress and apoptosis induced by hyperglycaemia"},{"title3":"Serum- and glucocorticoid-inducible kinase 1 delay the onset of endothelial senescence by directly interacting with human telomerase reverse transcriptase"},{"title3":"Downregulation of the glucocorticoid-induced leucine zipper (GILZ) promotes vascular inflammation"},{"title3":"Comparative effects of recombinant human activated protein C and dexamethasone in experimental septic shock"},{"title3":"Rapid nontranscriptional activation of endothelial nitric oxide synthase mediates increased cerebral blood flow and stroke protection by corticosteroids"},{"title3":"Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase"},{"title3":"Hydrocortisone preserves the vascular barrier by protecting the endothelial glycocalyx"},{"title3":"TNF-alpha induced shedding of the endothelial glycocalyx is prevented by hydrocortisone and antithrombin"},{"title3":"Dexamethasone effects on vascular flow and organ injury in septic mice"},{"title3":"Glucocorticoids and vascular reactivity"},{"title3":"Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells"},{"title3":"Effects of hydrocortisone on microcirculatory alterations in patients with septic shock"},{"title3":"Low-dose hydrocortisone during severe sepsis: effects on microalbuminuria"},{"title3":"Plasma and BAL cytokine response to corticosteroid rescue treatment in late ARDS"},{"title3":"Effects of methylprednisolone infusion on markers of inflammation, coagulation, and angiogenesis in early acute respiratory distress syndrome"},{"title3":"Aldosterone and vascular mineralocorticoid receptors in murine endotoxic and human septic shock"},{"title3":"On the origin of mitosing cells"},{"title3":"Beyond retrograde and anterograde signalling: mitochondrial-nuclear interactions as a means for evolutionary adaptation and contemporary disease susceptibility"},{"title3":"The role of the host defence response in the progression and outcome of ARDS: pathophysiological correlations and response to glucocorticoid treatment"},{"title3":"Mitochondrial functions modulate neuroendocrine, metabolic, inflammatory, and transcriptional responses to acute psychological stress"},{"title3":"An energetic view of stress: focus on mitochondria"},{"title3":"Mitochondria: in sickness and in health"},{"title3":"Mitochondria as key components of the stress response"},{"title3":"Mitochondria: master regulators of danger signalling"},{"title3":"Reactive oxygen species: radical factors in the evolution of animal life: a molecular timescale from Earth's earliest history to the rise of complex life"},{"title3":"The role of mitochondrial dysfunction in sepsis-induced multi-organ failure"},{"title3":"Glucocorticoids increase protein carbonylation and mitochondrial dysfunction"},{"title3":"New insights into the role of mitochondrial calcium homeostasis in cell migration"},{"title3":"Circulating mitochondrial DNA at the crossroads of mitochondrial dysfunction and inflammation during aging and muscle wasting disorders"},{"title3":"Dynamic regulation of mitochondrial function by glucocorticoids"},{"title3":"Mitochondria in lung biology and pathology: more than just a powerhouse"},{"title3":"Cross-talk between HPA-axis-increased glucocorticoids and mitochondrial stress determines immune responses and clinical manifestations of patients with sepsis"},{"title3":"Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation"},{"title3":"Role of oxidative stress and mitochondrial dysfunction in sepsis and potential therapies"},{"title3":"Enhanced expression of intranuclear NF-kappa B in primed polymorphonuclear leukocytes in systemic inflammatory response syndrome patients"},{"title3":"Mitohormesis: promoting health and lifespan by increased levels of Reactive Oxygen Species (ROS)"},{"title3":"Oxidative stress mitochondrial dysfunction in sepsis"},{"title3":"Serum thiamine concentration and oxidative stress as predictors of mortality in patients with septic shock"},{"title3":"Metabolome alterations in severe critical illness and Vitamin D status"},{"title3":"How to give vitamin C a cautious but fair chance in severe sepsis"},{"title3":"The rise of mitochondria in medicine"},{"title3":"Mitochondrial dysfunction in sepsis"},{"title3":"Association between mitochondrial dysfunction and severity and outcome of septic shock"},{"title3":"Widespread down-regulation of cardiac mitochondrial and sarcomeric genes in patients with sepsis"},{"title3":"Peripheral blood mononuclear cells demonstrate mitochondrial damage clearance during sepsis"},{"title3":"Vitamin C mitigates oxidative stress and tumor necrosis factor-alpha in severe community-acquired pneumonia and LPS-induced macrophages"},{"title3":"Mitochondrial dysfunction increases pro-inflammatory cytokine production and impairs repair and corticosteroid responsiveness in lung epithelium"},{"title3":"Overproduction of nitric oxide by endothelial cells and macrophages contributes to mitochondrial oxidative stress in adrenocortical cells and adrenal insufficiency during endotoxemia"},{"title3":"Circulating mitochondrial DAMPs cause inflammatory responses to injury"},{"title3":"Circulating mitochondrial DNA in patients in the ICU as a marker of mortality: derivation and validation"},{"title3":"Plasma mitochondrial DNA and metabolomic alterations in severe critical illness"},{"title3":"Fall in circulating mononuclear cell mitochondrial DNA content in human sepsis"},{"title3":"Role of mitochondria in toxic oxidative stress"},{"title3":"[Septic shock and selenium administration]"},{"title3":"Glucocorticoid receptors and other nuclear transcription factors in mitochondria and possible functions"},{"title3":"Glucocorticoids induce mitochondrial gene transcription in HepG2 cells: role of the mitochondrial glucocorticoid receptor"},{"title3":"Glucocorticoids suppress mitochondrial oxidant production via upregulation of uncoupling protein 2 in hyperglycemic endothelial cells"},{"title3":"Thioredoxin: a key regulator of cardiovascular homeostasis"},{"title3":"Interaction of mitochondrial thioredoxin with glucocorticoid receptor and NF-kappaB modulates glucocorticoid receptor and NF-kappaB signalling in HEK-293 cells"},{"title3":"Thioredoxin: a redox-regulating cellular cofactor for glucocorticoid hormone action. Cross talk between endocrine control of stress response and cellular antioxidant defense system"},{"title3":"Changes in CRH and ACTH synthesis during experimental and human septic shock"},{"title3":"Adrenocortical function during prolonged critical illness and beyond: a prospective observational study"},{"title3":"Mortality of septic mice strongly correlates with adrenal gland inflammation"},{"title3":"Redox manipulation of DNA binding activity and BuGR epitope reactivity of the glucocorticoid receptor"},{"title3":"Restoration of the glucocorticoid receptor function by the phosphodiester compound of vitamins C and E, EPC-K1 (L-ascorbic acid 2-[3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6 -yl hydrogen phosphate] potassium salt), via a redox-dependent mechanism"},{"title3":"Importin-7 mediates glucocorticoid receptor nuclear import and is impaired by oxidative stress, leading to glucocorticoid insensitivity"},{"title3":"Inhibition of glucocorticoid receptor binding by nitric oxide in endotoxemic rats"},{"title3":"Neuronal nitric oxide synthase is an endogenous negative regulator of glucocorticoid receptor in the hippocampus"},{"title3":"Redox-dependent regulation of nuclear import of the glucocorticoid receptor"},{"title3":"Inhibition of glucocorticoid receptor binding by nitric oxide"},{"title3":"Rapid nongenomic inhibitory effects of glucocorticoids on phagocytosis and superoxide anion production by macrophages"},{"title3":"Glucocorticoids attenuate septic acute kidney injury"},{"title3":"Immunologic and hemodynamic effects of &quot;low-dose&quot; hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study"},{"title3":"Stress doses of hydrocortisone in septic shock: beneficial effects on opsonization-dependent neutrophil functions"},{"title3":"Risk of death does not alter the efficacy of hydrocortisone therapy in a mouse E. coli pneumonia model : risk and corticosteroids in sepsis"},{"title3":"Vitamin therapy in critically ill patients: focus on thiamine, vitamin C, Vitamin D"},{"title3":"Ascorbic acid, corticosteroids, and thiamine in sepsis: a review of the biologic rationale and the present state of clinical evaluation"},{"title3":"Vitamin B1 in critically ill patients: needs and challenges"},{"title3":"Randomized, double-blind, placebo-controlled trial of thiamine as a metabolic resuscitator in septic shock: a pilot study"},{"title3":"Thiamine deficiency in critically ill patients with sepsis"},{"title3":"Prevalence of vitamin deficiencies on admission: relationship to hospital mortality in critically ill patients"},{"title3":"Effect of thiamine administration on lactate clearance and mortality in patients with septic shock"},{"title3":"Vitamin D and critical illness outcomes"},{"title3":"The role of Vitamin D in the immune system as a pro-survival molecule"},{"title3":"Vitamin D in inflammatory diseases"},{"title3":"The Vitamin D analogue TX 527 blocks NF-kappaB activation in peripheral blood mononuclear cells of patients with Crohn's disease"},{"title3":"Vitamin D enhances glucocorticoid action in human monocytes: involvement of granulocyte-macrophage colony-stimulating factor and mediator complex subunit 14"},{"title3":"The impact of Vitamin D levels on inflammatory status: a systematic review of immune cell studies"},{"title3":"Altered blood levels of Vitamin D, cathelicidin and parathyroid hormone in patients with sepsis-a pilot study"},{"title3":"Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1"},{"title3":"Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1"},{"title3":"Anti-inflammatory and corticosteroid-enhancing actions of Vitamin D in monocytes of patients with steroid-resistant and those with steroid-sensitive asthma"},{"title3":"Vitamin D affects glucocorticoid action in target cells"},{"title3":"Are statins analogues of Vitamin D?"},{"title3":"Vitamin D augments glucocorticosteroid efficacy via inhibition of mTORc1"},{"title3":"Vitamin D deficiency impacts on expression of toll-like receptor-2 and cytokine profile: a pilot study"},{"title3":"Vitamin D upregulates glutamate cysteine ligase and glutathione reductase, GSH formation. and decreases ROS and MCP-1 and IL-8 secretion in high-glucose exposed U937 monocytes"},{"title3":"1alpha, 25-Dihydroxyvitamin D3 regulates mitochondrial oxygen consumption and dynamics in human skeletal muscle cells"},{"title3":"Improving the Vitamin D status of Vitamin D deficient adults is associated with improved mitochondrial oxidative function in skeletal muscle"},{"title3":"Vitamin D kinetics in the acute phase of critical illness: a prospective observational study"},{"title3":"Martucci G, Mcnally JD. When not to use meta-analysis: analysing the meta-analyses on Vitamin D in critical care"},{"title3":"Effect of high-dose Vitamin D3 on hospital length of stay in critically ill patients with Vitamin D deficiency: the VITdAL-ICU randomized clinical trial"},{"title3":"Early high-dose Vitamin D3 for critically ill, Vitamin D-deficient patients"},{"title3":"Is vitamin C beneficial to patients with CAP?"},{"title3":"The genetics of vitamin C loss in vertebrates"},{"title3":"Vitamin C for the treatment of sepsis: the scientific rationale"},{"title3":"Vitamin C: the known and the unknown and Goldilocks"},{"title3":"Vitamin C and immune cell function in inflammation and cancer"},{"title3":"The Warburg effect then and now: from cancer to inflammatory diseases"},{"title3":"Ascorbic acid: its role in immune system and chronic inflammation diseases"},{"title3":"Vitamin C is an important cofactor for both adrenal cortex and adrenal medulla"},{"title3":"Effects of ascorbic acid deficiency on adrenal mitochondrial hydroxylations in guinea pigs"},{"title3":"Dexamethasone induces sodium-dependant vitamin C transporter in a mouse osteoblastic cell line MC3T3-E1"},{"title3":"Vitamin C, and thiamine for the treatment of severe sepsis and septic shock: a retrospective before-after study"},{"title3":"The adrenal-vitamin C axis: from fish to guinea pigs and primates"},{"title3":"Vitamin C inhibits NF-kappaB activation by TNF via the activation of p38 mitogen-activated protein kinase"},{"title3":"Vitamin C suppresses TNFalpha-induced NFkappaB activation by inhibiting IkappaBalpha phosphorylation"},{"title3":"Ascorbate protects against vascular leakage in cecal ligation and puncture-induced septic peritonitis"},{"title3":"Glucocorticosteroids as adjunctive therapy for acute respiratory distress syndrome and sepsis? yes, but not as monotherapy"},{"title3":"Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis"},{"title3":"Doctor:your septic patients have scurvy!"},{"title3":"Effect of high-dose ascorbic acid on vasopressor's requirement in septic shock"},{"title3":"Effect of vitamin C infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respiratory failure: the CITRIS-ALI randomized clinical trial"},{"title3":"The resolution of inflammation: principles and challenges"},{"title3":"Glucocorticoid receptor function is decreased in neutrophils during endotoxic shock"},{"title3":"1161: Timeliness of corticosteroid use in icu patients with pneumonia and ards"},{"title3":"Efficacy of corticosteroids in acute respiratory distress syn-drome: an observational study"},{"title3":"early administration of hydrocortisone replacement after the advent of septic shock: impact on survival and immune response*"},{"title3":"Early initiation of low-dose corticosteroid therapy in the management of septic shock: a retrospective observational study"},{"title3":"Glucocorticoid treatment in community-acquired pneumonia"},{"title3":"Hydrocortisone plus fludrocortisone for adults with septic shock"},{"title3":"Immune effects of corticosteroids in sepsis"},{"title3":"Vasopressin deficiency contributes to the vasodilation of septic shock"},{"title3":"Circulating vasopressin levels in septic shock"},{"title3":"Dieter ayers for the, and I. Septic shock trial, interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock"},{"title3":"The Australian-New Zealand intensive care society clinical trials, adjunctive glucocorticoid therapy in patients with septic shock"},{"title3":"Successful treatment of acute lung injury with pitavastatin in septic mice: potential role of glucocorticoid receptor expression in alveolar macrophages"},{"title3":"Melatonin regulates catecholamine biosynthesis by modulating bone morphogenetic protein and glucocorticoid actions"},{"title3":"Influence of drug treatment on glucocorticoid receptor levels in patients with coronary heart disease"},{"title3":"Mechanistic insights into the protective impact of zinc on sepsis"},{"title3":"The protection potential of antioxidant vitamins against acute respiratory distress syndrome: a rat trial"},{"title3":"An historical review of glucocorticoid treatment in sepsis. Disease pathophysiology and the design of treatment investigation"},{"title3":"Prolonged glucocorticoid treatment is associated with improved ARDS outcomes: analysis of individual patients' data from four randomized trials and trial-level meta-analysis of the updated literature"},{"title3":"CONSORT 2010 comments"},{"title3":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations"},{"title3":"Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology"},{"title3":"Timing, method and discontinuation of hydrocortisone administration for septic shock patients"},{"title3":"Bolus or continuous hydrocortisone-that is the question"},{"title3":"Effect of mode of hydrocortisone administration on glycemic control in patients with septic shock: a prospective randomized trial"},{"title3":"Immune regulation by glucocorticoids"},{"title3":"Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids"},{"title3":"Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part I): society of critical care medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) (2017)"},{"title3":"Relative immunosuppressive potency of therapeutic corticosteroids measured by whole blood lymphocyte proliferation"},{"title3":"Prednisone and methylprednisolone disposition in the lung"},{"title3":"Methylprednisolone achieves greater concentrations in the lung than prednisolone. A pharmacokinetic analysis"},{"title3":"Penetration of corticosteroids into the lung - evidence for a difference between methylprednisolone and prednisolone"},{"title3":"Evaluation of AP-1 and NF-kB inhibitory potency for oral glucocorticoids"},{"title3":"Different glucocorticoids vary in their genomic and non-genomic mechanism of action in A549 cells"},{"title3":"Corticosteroid treatment in severe community-acquired pneumonia: duration of treatment affects control of systemic inflammation and clinical improvement"},{"title3":"Adjunctive corticosteroids for pneumocystis jiroveci pneumonia in patients with HIV infection"},{"title3":"Why glucocorticoid withdrawal may sometimes be as dangerous as the treatment itself"},{"title3":"Prospective analysis of adrenal function in patients with acute exacerbations of COPD: the reduction in the Use of Corticosteroids in Exacerbated COPD (REDUCE) trial"},{"title3":"Potentiation of butylated-hydroxytoluene-induced acute lung damage by oxygen. Effects of prednisolone and indomethacin"},{"title3":"Enhanced acute lung damage following corticosteroid treatment"},{"title3":"La voie, corticosteroids as adjunctive therapy for severe pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A double-blind, placebo-controlled trial"},{"title3":"Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome"},{"title3":"An exploratory reanalysis of the randomized trial on efficacy of corticosteroids as rescue therapy for the late phase of acute respiratory distress syndrome"}]},{"title2":"Penetration of corticosteroids into the lung: evidence for a difference between methylprednisolone and prednisolone","References":[]},{"title2":"Dexamethasone in hospitalized patients with Covid-19 - preliminary report [published online ahead of print July 17, 2020]","References":[]},{"title2":"Prolonged glucocorticoid treatment is associated with improved ARDS outcomes: analysis of individual patients' data from four randomized trials and trial-level meta-analysis of the updated literature","References":[]},{"title2":"Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study","References":[]},{"title2":"Clinical recommendations from an observational study on MERS: glucocorticoids was benefit in treating SARS patients","References":[]},{"title2":"Treatment of severe acute respiratory syndrome with glucosteroids: the Guangzhou experience","References":[{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Treatment of severe acute respiratory syndrome"},{"title3":"Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China"},{"title3":"Development of a standard treatment protocol for severe acute respiratory syndrome"},{"title3":"High dose pulse versus non-pulse corticosteroid regimens in severe acute respiratory syndrome"},{"title3":"Use of glucocorticoid in treatment of severe acute respiratory syndrome cases"},{"title3":"Glucocorticoid-induced diabetes in severe acute respiratory syndrome: the impact of high dosage and duration of methylprednisolone therapy"},{"title3":"Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak"},{"title3":"Management and prevention of SARS in China"},{"title3":"Medical treatment of viral pneumonia including SARS in immunocompetent adult"},{"title3":"SARS: pharmacotherapy"},{"title3":"High dose intravenous methylprednisolone in the treatment of severe acute respiratory syndrome"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"The clinical characteristics of secondary infections of lower respiratory tract in severe acute respiratory syndrome"},{"title3":"Nosocomial infections and nosocomial pneumonia"},{"title3":"Chinese Medical Association. Guidelines for management of atypical pneumonia (SARS)"},{"title3":"Comparative study of clinical characteristics and prognosis of clinically diagnosed SARS patients with positive and negative serum SARS coronavirus-specific antibodies test"},{"title3":"A preliminary study of serum antibody level in SARS patients"},{"title3":"Severe acute respiratory syndrome (SARS): a challenge for diagnosis and treatment"},{"title3":"Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003"},{"title3":"Glucocorticoid in the treatment of severe acute respiratory syndrome patients: a preliminary report"},{"title3":"Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients"},{"title3":"Coronavirus-positive nasopharyngeal aspirate as predictor for severe acute respiratory syndrome mortality"},{"title3":"High dose methylprednisolone in a porcine model of ARDS induced by endotoxemia"},{"title3":"Ineffectiveness of high dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock"},{"title3":"High dose corticosteroids in patients with the adult respiratory distress syndrome"},{"title3":"Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome"},{"title3":"Respiratory and cadiovascular management of septic ALI-ARDS and shock"},{"title3":"Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS: plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome"},{"title3":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome"},{"title3":"Prolonged disturbances ofin vitrocytokine production in patients with severe acute respiratory syndrome treated with ribavirin and steroids"},{"title3":"Report on the investigation of lower extremity osteonecrosis with magnetic resonance imaging in recovered severe acute respiratory syndrome in Guangzhou"},{"title3":"Osteonecrosis of hip and knee in patients with severe acute respiratory syndrome treated with steroids"},{"title3":"Factors of avascular necrosis of femoral head and osteoporosis in SARS patients' convalescence"},{"title3":"Avascular necrosis of bone in severe acute respiratory syndrome"}]},{"title2":"Corticosteroid treatment of severe acute respiratory syndrome in Hong Kong","References":[{"title3":"Our strategies for fighting severe acute respiratory syndrome (SARS)"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Development of a standard treatment protocol for severe acute respiratory syndrome"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"High dose pulse versus non-pulse corticosteroid regimens in severe acute respiratory syndrome"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Severe acute respiratory syndrome treatment: present status and future strategy"},{"title3":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome"},{"title3":"Index patient and SARS outbreak in Hong Kong"},{"title3":"Severe acute respiratory syndrome (SARS) in Singapore: clinical features of index patient and initial contacts"},{"title3":"Glucocorticoid in the treatment of severe acute respiratory syndrome patients: a preliminary report"},{"title3":"Fatal aspergillosis in a patient with SARS who was treated with corticosteroids"},{"title3":"Case definitions for surveillance of severe acute respiratory syndrome (SARS)"},{"title3":"Estimation of skin metabolism and blood flow with tcPO2 and tcPO2 electrodes by cuff occlusion of the circulation"},{"title3":"The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination"},{"title3":"Critically ill patients with severe acute respiratory distress syndrome"},{"title3":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory distress syndrome"},{"title3":"Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus"},{"title3":"In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compound"},{"title3":"Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines"},{"title3":"Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome"},{"title3":"Dynamic changes in blood cytokine levels as clinical indicators in severe actue respiratory syndrome"},{"title3":"Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study"},{"title3":"The immunosuppressive potency of various steroids on peripheral blood lymphocytes, T cells, NK and K cells"},{"title3":"Relative immunosuppressive potency of various corticosteroids measured in vitro"},{"title3":"Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Outcome of coronavirus-associated severe acute respiratory syndrome using a standard treatment protocol"},{"title3":"Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China"},{"title3":"Severe acute respiratory syndrome: clinical outcome and prognostic correlates"},{"title3":"Coronavirus-positive nasopharyngeal aspirate as predictor for severe acute respiratory syndrome mortality"},{"title3":"Effects of early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentration in adult patients"},{"title3":"Cytokines IL-1beta, IL-6, and TNF-alpha enhance in vitro growth of bacteria"}]},{"title2":"Effect of low-to-moderate-dose corticosteroids on mortality of hospitalized adolescents and adults with influenza A(H1N1)pdm09 viral pneumonia","References":[{"title3":"Intensive cytokine induction in pandemic H1N1 influenza virus infection accompanied by robust production of IL-10 and IL-6"},{"title3":"Influenza pneumonia among adolescents and adults: a concurrent comparison between influenza A (H1N1) pdm09 and A (H3N2) in the post-pandemic period"},{"title3":"High levels of virus-specific CD4+ T cells predict severe pandemic influenza A virus infection"},{"title3":"Lung pathology in fatal novel human influenza A (H1N1) infection"},{"title3":"2009 pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States"},{"title3":"Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California"},{"title3":"Corticosteroid treatment ameliorates acute lung injury induced by 2009 swine origin influenza A (H1N1) virus in mice"},{"title3":"Combination anti-inflammatory and antiviral therapy of influenza in a cotton rat model"},{"title3":"H1N1 influenza A virus-associated acute lung injury: response to combination oseltamivir and prolonged corticosteroid treatment"},{"title3":"Hyperactive immune cells (T cells) may be responsible for acute lung injury in influenza virus infections: a need for early immune-modulators for severe cases"},{"title3":"Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection"},{"title3":"Corticosteroid therapy in patients with primary viral pneumonia due to pandemic (H1N1) 2009 influenza"},{"title3":"Corticosteroid treatment in critically ill patients with pandemic influenza A/H1N1 2009 infection: analytic strategy using propensity scores"},{"title3":"Early corticosteroids in severe influenza A/H1N1 pneumonia and acute respiratory distress syndrome"},{"title3":"Pro: the illegitimate crusade against corticosteroids for severe H1N1 pneumonia"},{"title3":"Con: corticosteroids are not indicated for treatment of acute lung injury from H1N1 viral pneumonia"},{"title3":"The influence of corticosteroid treatment on the outcome of influenza A(H1N1pdm09)-related critical illness"},{"title3":"Viral loads and duration of viral shedding in adult patients hospitalized with influenza"},{"title3":"Prolonged viral shedding in pandemic influenza A(H1N1): clinical significance and viral load analysis in hospitalized patients"},{"title3":"Clinical management of human infection with pandemic (H1N1) 2009: revised guidance, November 2009"},{"title3":"Effect of Corticosteroid Therapy on Influenza-Related Mortality: A Systematic Review and Meta-analysis"},{"title3":"Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial"},{"title3":"Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial"},{"title3":"Low-dose corticosteroid use and mortality in severe community-acquired pneumonia patients"},{"title3":"A case-control study on risk factors associated with death in pregnant women with severe pandemic H1N1 infection"},{"title3":"Corticosteroid therapy in intensive care unit patients with PCR-confirmed influenza A(H1N1) infection in Finland"},{"title3":"Clinical experience with severe 2009 H1N1 influenza in the intensive care unit at King Saud Medical City, Saudi Arabia"},{"title3":"Clinical and prognostic features of patients with pandemic 2009 influenza A (H1N1) virus in the intensive care unit"},{"title3":"Effect of immunomodulatory therapies in patients with pandemic influenza A (H1N1) 2009 complicated by pneumonia"},{"title3":"Hospitalized adult patients with 2009 influenza A(H1N1) in Beijing, China: risk factors for hospital mortality"},{"title3":"Corticosteroid therapy for acute lung injury, acute respiratory distress syndrome, and severe pneumonia: a meta-analysis of randomized controlled trials"},{"title3":"Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis"},{"title3":"Comparison of patients hospitalized with influenza A subtypes H7N9, H5N1, and 2009 pandemic H1N1"},{"title3":"Antiviral therapy and outcomes of patients with pneumonia caused by influenza A pandemic (H1N1) virus"},{"title3":"Neuraminidase inhibitors, superinfection and corticosteroids affect survival of influenza patients"},{"title3":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group"},{"title3":"Mortality prediction to hospitalized patients with influenza pneumonia: PO/FiO combined lymphocyte count is the answer"},{"title3":"Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenza"},{"title3":"Mx1 reveals innate pathways to antiviral resistance and lethal influenza disease"}]},{"title2":"COVID-19: disease pathways and gene expression changes predict methylprednisolone can improve out- come in severe cases [Preprint]","References":[]},{"title2":"Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids","References":[]},{"title2":"Virological assessment of hospitalized patients with COVID-2019","References":[]},{"title2":"Re: Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19","References":[]},{"title2":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome","References":[]},{"title2":"COVID-19: consider cytokine storm syndromes and immunosuppression","References":[{"title3":"Coronavirus disease 2019 (COVID-19)situation report - 52"},{"title3":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China"},{"title3":"Adult haemophagocytic syndrome"},{"title3":"Macrophage activation-like syndrome: a distinct entity leading to early death in sepsis"},{"title3":"Pulmonary involvement in patients with hemophagocytic lymphohistiocytosis"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"},{"title3":"Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase iii trial"},{"title3":"A multicenter, randomized controlled trial for the efficacy and safety of tocilizumab in the treatment of new coronavirus pneumonia (COVID-19)"},{"title3":"Baricitinib as potential treatment for 2019-nCoV acute respiratory disease"},{"title3":"Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome"}]}]},{"title1":"Epidemiology and clinical course of COVID-19 in Shanghai, China","References":[{"title2":"A novel coronavirus from patients with pneumonia in China, 2019","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Inferring the hosts of coronavirus using dual statistical models based on nucleotide composition"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"2019 novel coronavirus (2019-nCoV) outbreak: a new challenge"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan"},{"title3":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China"},{"title3":"Novel Wuhan (2019-nCoV) coronavirus"},{"title3":"Severe acute respiratory syndrome coronavirus phylogeny: toward consensus"},{"title3":"Diagnosis and treatment of new coronavirus pneumonia (trial version 7) [J / OL]. Tianjin J Tradit Chin Med. 2020;1-5. http://kns.cnki.net/kcms/detail/12.1349.R.20200304.1638.006.html. Accessed 3 June 2020."},{"title3":"Clinical outcome of standardized oxygen therapy nursing strategy in COVID-19"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus"},{"title3":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection"},{"title3":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV"},{"title3":"Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients"},{"title3":"Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study"},{"title3":"C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early"},{"title3":"Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study"},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China"},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Human ipsc-derived cardiomyocytes are susceptible to Sars-Cov-2 infection"},{"title3":"Cardiovascular complications in COVID-19"},{"title3":"COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?"},{"title3":"Endothelial cell infection and endotheliitis in COVID-19"}]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster","References":[{"title3":"CHP closely monitors cluster of pneumonia cases on Mainland"},{"title3":"CHP provides further information on cluster of pneumonia cases in Wuhan"},{"title3":"Wuhan wet market closes amid pneumonia outbreak"},{"title3":"Viral load in patients infected with pandemic H1N1 2009 influenza A virus"},{"title3":"Saliva as a diagnostic specimen for testing respiratory virus by a point-of-care molecular assay: a diagnostic validity study"},{"title3":"Evaluation of NxTAG Respiratory pathogen panel and comparison with xTAG respiratory viral panel fast v2 and film array respiratory panel for detecting respiratory pathogens in nasopharyngeal aspirates and swine/avian-origin influenza A subtypes in culture isolates"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Zika virus infection in dexamethasone-immunosuppressed mice demonstrating disseminated infection with multi-organ involvement including orchitis effectively treated by recombinant type I interferons"},{"title3":"High prevalence of four novel astrovirus genotype species identified from rodents in China"},{"title3":"Metagenomic analysis of viromes of dromedary camel fecal samples reveals large number and high diversity of circoviruses and picobirnaviruses"},{"title3":"Identification of a novel bat papillomavirus by metagenomics"},{"title3":"Metagenomic nanopore sequencing of influenza virus direct from clinical respiratory samples"},{"title3":"Severe acute respiratory syndrome (SARS) coronavirus ORF8 protein is acquired from SARS-related coronavirus from greater horseshoe bats through recombination"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection"},{"title3":"A patient with asymptomatic severe acute respiratory syndrome (SARS) and antigenemia from the 2003-2004 community outbreak of SARS in Guangzhou, China"},{"title3":"Viral replication in the nasopharynx is associated with diarrhea in patients with severe acute respiratory syndrome"},{"title3":"Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease"},{"title3":"Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus"},{"title3":"Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection"},{"title3":"Viral loads in clinical specimens and SARS manifestations"},{"title3":"Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome"},{"title3":"Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia"},{"title3":"Discovery of seven novel mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus"},{"title3":"Discovery of a novel coronavirus, China Rattus coronavirus HKU24, from Norway rats supports the murine origin of Betacoronavirus 1 and has implications for the ancestor of Betacoronavirus lineage A"},{"title3":"Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Antigenic cross-reactivity between severe acute respiratory syndrome-associated coronavirus and human coronaviruses 229E and OC43"}]},{"title2":"Presumed asymptomatic carrier transmission of COVID-19","References":[]},{"title2":"Potential presymptomatic transmission of SARS-CoV-2, Zhejiang province, China, 2020","References":[{"title3":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR."}]},{"title2":"Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"A novel coronavirus genome identified in a cluster of pneumonia cases - Wuhan, China 2019-2020"},{"title3":"A familiar cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China"},{"title3":"A novel coronavirus outbreak of global health concern"},{"title3":"China coronavirus: WHO declares international emergency as death toll exceeds 200"},{"title3":"Severe acute respiratory syndrome: clinical and laboratory manifestations"},{"title3":"The Middle East Respiratory Syndrome (MERS)"},{"title3":"The novel coronavirus in Wuhan, China: challenges for global health governance"},{"title3":"The extent of transmission of novel coronavirus in Wuhan, China, 2020"},{"title3":"Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia"},{"title3":"Chest CT for typical 2019-nCoV pneumonia: relationship to negative RT-PCR testing"},{"title3":"CT manifestations of two cases of 2019 novel coronavirus (2019-nCoV) pneumonia"},{"title3":"Emerging coronavirus 2019-nCoV pneumonia"},{"title3":"Imaging profile of the COVID-19 infection: radiologic findings and literature review"},{"title3":"Chest imaging appearance of COVID-19 infection"},{"title3":"The many faces of COVID-19: spectrum of imaging manifestations"},{"title3":"Longitudinal CT findings in COVID-19 pneumonia: case presenting organizing pneumonia pattern"},{"title3":"Spectrum of chest CT findings in a familial cluster of COVID-19 infection"},{"title3":"COVID-19 infection presenting with CT halo sign"},{"title3":"CT imaging features of 2019 novel coronavirus (2019-nCoV)"},{"title3":"Fleischner Society: glossary of terms for thoracic imaging"},{"title3":"China's Hubei reports jump in new cases of COVID-19 after diagnosis criteria revision"}]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title3":"The novel coronavirus originating in Wuhan, China: challenges for global health governance"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Chinese management guideline for COVID-19 (version 6.0)"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Middle East respiratory syndrome"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Predictors of mortality in Middle East respiratory syndrome (MERS)"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"The immunopathogenesis of sepsis in elderly patients"},{"title3":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Serial evaluation of the SOFA score to predict outcome in critically ill patients"},{"title3":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network"},{"title3":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study"},{"title3":"Acute pneumonia and the cardiovascular system"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015"},{"title3":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia"},{"title3":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality"},{"title3":"Cardiovascular complications of acute respiratory infections: current research and future directions"},{"title3":"Regulation of ACE2 in cardiac myocytes and fibroblasts"},{"title3":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]},{"title2":"Characteristics of COVID-19 infection in Beijing","References":[]},{"title2":"Clinical Characteristics of Imported Cases of COVID-19 in Jiangsu Province: A Multicenter Descriptive Study [published online ahead of print, 2020 Feb 29]","References":[]},{"title2":"Clinical features predicting mortality risk in patients with viral pneumonia: The MuLBSTA Score","References":[]},{"title2":"Clinical features of deaths in the novel coronavirus epidemic in China","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"  . State Council Information Office Press Conference. http://www.nhc.gov.cn/xwzb/webcontroller.do?titleSeq=11209&amp;gecstype=1. Accessed February 3, 2020."},{"title3":"Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross-species transmission from snake to human"},{"title3":"  . Wuhan Municipal Health Commission's report on viral pneumonia with unknown etiology. http://www.nhc.gov.cn/xcs/yqtb/202001/1beb46f061704372b7ca41ef3e682229.shtml. Accessed February 3, 2020."},{"title3":"  . Hubei Province Health Commission's report on pneumonia of new coronavirus infection, 2020. http://wjw.hubei.gov.cn/fbjd/dtyw/202001/t20200124_2014626.shtml. Accessed February 3, 2020."},{"title3":"  . Hubei Province Health Commission's report on pneumonia of new coronavirus infection, 2020. http://wjw.hubei.gov.cn/fbjd/dtyw/202001/t20200125_2014854.shtml. Accessed February 3, 2020."},{"title3":"  . Epidemic situation of the new coronavirus infection on January 23. http://www.nhc.gov.cn/xcs/yqtb/202001/5d19a4f6d3154b9fae328918ed2e3c8a.shtml. Accessed February 3, 2020."},{"title3":"  . Seventh routine news briefing on pneumonia prevention and control of new coronavirus infection. http://cq.cqnews.net/jrzb2/col607342.htm. Accessed February 3, 2020."},{"title3":"  . Press conference on the new coronavirus epidemic prevention and control. http://www.ha.xinhuanet.com/news/2020-01/31/c_1125515584.htm. Accessed February 3, 2020."},{"title3":"  . Heilongjiang: open and transparent to the public and the initiative to fight the epidemic. http://www.gov.cn/xinwen/2020-02/01/content_5473540.htm. Accessed February 3, 2020."},{"title3":"  . The second case of new coronavirus pneumonia confirmed in our province. http://www.hebwst.gov.cn/index.do?id=394918&amp;templet=content&amp;cid=45. Accessed February 3, 2020."},{"title3":"  . Thirteen new coronavirus pneumonia cases in Chengdu. http://cdwjw.chengdu.gov.cn/cdwjw/gzdt/2020-01/30/content_516b4576ecc74698b88344d133dd211e.shtml. Accessed February 3, 2020."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health:the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Risk factors for hypertension and diabetes among floating population in Hubei Province: a cross-section survey"}]},{"title2":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention","References":[]},{"title2":"Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease","References":[{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Recent advances in the detection of respiratory virus infection in humans"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Coronaviruses: genome structure, replication, and pathogenesis"},{"title3":"Infectious diseases. Clues to the animal origins of SARS"},{"title3":"Severe acute respiratory syndrome: historical, epidemiologic, and clinical features"},{"title3":"Complemented palindromic small RNAs first discovered from SARS coronavirus"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study"},{"title3":"An investigation of multimorbidity measures as risk factors for pneumonia in elderly frail patients admitted to hospital"},{"title3":"Impact of age and comorbidity on cause and outcome in community-acquired pneumonia"},{"title3":"The Deyo-Charlson and Elixhauser-van Walraven comorbidity indices as predictors of mortality in critically ill patients"},{"title3":"Common co-morbidities are challenging in the diagnosis of middle east respiratory syndrome (MERS-CoV) in Saudi Arabia"},{"title3":"Predictive factors of depressive symptoms of elderly patients with cancer receiving first-line chemotherapy"},{"title3":"Historical review of pandemic influenza A in Taiwan, 2009"},{"title3":"Influenza B-associated rhabdomyolysis in Taiwanese children"},{"title3":"Severe respiratory failure associated with influenza B virus infection"},{"title3":"Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial"},{"title3":"Early corticosteroid treatment for severe pneumonia caused by 2009 H1N1 influenza virus"}]}]}]}